PHARMACEUTICAL COMPOSITION CONTAINING RIBONUCLEOTIDE POLYMERASE

摘要

A method and composition are provided for treatment of disorders involving immunological dysfunction. The invention comprises the administration of a low level of ribonucleotide polymerase protein or a derivative thereof to a human or animal with an immune dysfunction disorder.